DOI QR코드

DOI QR Code

COVID-19 백신 접종 후 발생한 전신 부종에 대한 한양방 복합치료 치험 1례

A Case of Generalized Edema in a Patient after COVID-19 Vaccination Improved by a Combined Korean-Western Medicine Approach

  • 이영선 (경희대학교 대학원 임상한의학과) ;
  • 정소민 (경희대학교 대학원 임상한의학과) ;
  • 이한결 (경희대학교 대학원 임상한의학과) ;
  • 조기호 (경희대학교 대학원 임상한의학과) ;
  • 문상관 (경희대학교 대학원 임상한의학과) ;
  • 정우상 (경희대학교 대학원 임상한의학과) ;
  • 권승원 (경희대학교 대학원 임상한의학과)
  • Youngseon Lee (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Somin Jung (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Han-gyul Lee (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Ki-ho Cho (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Sang-kwan Moon (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Woo-sang Jung (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Seung-won Kwon (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
  • 투고 : 2023.09.21
  • 심사 : 2023.11.07
  • 발행 : 2023.10.30

초록

Background: According to Vaccine Adverse Events Reporting System data, generalized edema followed by the COVID-19 vaccine is uncommon, with only 333 reported cases, and of those, 224 (69%) are associated with the Pfizer-BioNTech vaccine. Case report: A 76-year-old male patient with heart failure with preserved ejection fraction presented with spontaneous generalized edema and otherwise normal cardiac exams following administration of BNT162b2 (Pfizer-BioNTech) COVID-19 vaccination that had lasted for approximately 60 days and was treated successfully using Korean medicine treatment. After the administration of Korean medicine treatment, the patient's symptoms in the bilateral limbs were dramatically controlled, without recurrence, for 2 months. As a result, generalized edema, which had been present for approximately 50 days, dramatically improved. Conclusion: This clinical case study suggests that a Korean medicine approach with Mokbangki-tang and Oryeong-san might be effective for the pleural effusion resolution of generalized edema after COVID-19 vaccination.

키워드

참고문헌

  1. Jo EJ. Adverse Reactions of COVID-19 Vaccines. J Clin Otolaryngol Head Neck Surg 2022;33(2):92-104.  https://doi.org/10.35420/jcohns.2022.33.2.92
  2. Ryu KJ, Kim DH. A Toxic Anterior Segment Syndrome-like Ocular Inflammatory Reaction after COVID-19 Vaccination. J Korean Ophthalmol Soc 2022;63(7):625-9.  https://doi.org/10.3341/jkos.2022.63.7.625
  3. Lizhi Z, Xiaoli J, Dongmei G. Effect and safety of press-needle on chronic heart failure. Journal of Traditional Chinese Medicine 2017;37(6):789-93.  https://doi.org/10.1016/S0254-6272(18)30042-6
  4. Bredy C, Ministeri M, Kempny A, Alonso-Gonzalez R, Swan L, Uebing A, et al. New York Heart Association (NYHA) classification in adults with congenital heart disease: relation to objective measures of exercise and outcome. European Heart Journal-Quality of Care and Clinical Outcomes 2018;4(1):51-8.  https://doi.org/10.1093/ehjqcco/qcx031
  5. Ye X, Ma T, Blais JE, Yan VK, Kang W, Chui CS, et al. Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease. Cardiovascular Research 2022;118(10):2329-38.  https://doi.org/10.1093/cvr/cvac068
  6. Ely JW, Osheroff JA, Chambliss ML, Ebell MH. Approach to leg edema of unclear etiology. J Am Board Fam Med 2006;19(2):148-60.  https://doi.org/10.3122/jabfm.19.2.148
  7. Park JJ, Choi DJ. Treatment of Heart Failure with Reduced Ejection Fraction: Current Update. Korean J Med 2015;88(2):127-34.  https://doi.org/10.3904/kjm.2015.88.2.127
  8. Lee IG. Differential Diagnosis and Treatment of Generalized Edema. Journal of the Korean Academy of Family Medicine 2003;24(1):6-10. 
  9. Pollock A, Hazelton C, Henderson CA, Angilley J, Dhillon B, Langhorne P, et al. Interventions for visual field defects in patients with stroke. Stroke 2012;43(4):e37-8.  https://doi.org/10.1161/STROKEAHA.111.639815
  10. Jeong YK, Kim SB, Yang JY, Moon SK, Jung WS, Kwon SW, et al. Two Case Studies of the Use of Oreong-san for a Chronic Subdural Hematoma. J Int Korean Med 2017;38(2):259-63.  https://doi.org/10.22246/jikm.2017.38.2.259
  11. Arumugam S, Watanabe K. Japanese Kampo medicines for the treatment of common diseases. 1st ed. USA: Academic Press; 2017, p. 182. 
  12. Kwon SW, Jin C, Cho KH. An herbal medicine prescription (Oreongsan) developed as a new alternative treatment in patients with chronic subdural hematoma: a narrative review. Integrative Medicine Research 2019;8(1):26-30.  https://doi.org/10.1016/j.imr.2018.11.003
  13. 元.鄧珍本金匱要略2-4b~2-5a. 北京: 燎原書店復刻版; 1988, p. 86-7. 
  14. Ezaki H, Ayaori M, Sato H, Maeno Y, Taniwaki M, Miyake T, et al. Effects of Mokuboito, a Japanese Kampo medicine, on symptoms in patients hospitalized for acute decompensated heart failure - A prospective randomized pilot study. Journal of Cardiology 2019;74(5):412-7.  https://doi.org/10.1016/j.jjcc.2019.05.003
  15. Cho HJ, Lee KS. Effects of Mokbanggi-tang on cardiac diuresis and heart rate. Journal of Korean Medicine 1984;5(1):28-34. 
  16. Nishida S, Satoh H. Vascular Pharmacology of Mokuboito (Mu-Fang-Yi-Tang) and Its Constituents on the Smooth Muscle and the Endothelium in Rat Aorta. eCAM 2007;4(3):335-41.  https://doi.org/10.1093/ecam/nel097
  17. Rosano G, Jankowska EA, Ray R, Metra M, Abdelhamid M, Adamopoulos S, et al. COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology. European journal of heart failure 2021;23(11):1806-18.  https://doi.org/10.1002/ejhf.2356
  18. Ye X, Ma T, Blais JE, Yan VK, Kang W, Chui CS, et al. Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease. Cardiovascular Research 2022;118(10):2329-38. https://doi.org/10.1093/cvr/cvac068